ALTSTATION.IO

International Flavors & Fragrances Inc. (IFF) Stock Analysis

By Nova Skye | AltStation.io | Updated October 14, 2026

Price

$88.42

Change

+4.07%

Market Cap

$22.56B

Avg Volume

1.7M

Company Overview

Headquartered in New York, International Flavors & Fragrances operates in the specialty chemicals industry within the basic materials sector. Incorporated in 1909, the business manufactures essential functional ingredients across four core segments: Taste, Food Ingredients, Health & Biosciences, and Scent. Its customers include global packaged food corporations, beverage producers, cosmetics companies, and personal care brands. IFF sells proprietary flavor compounds for sodas and snacks, fragrance formulations for perfumes and detergents, and specialized enzymes and cultures for food preservation and health applications.

IFF is an established global market leader, controlling an estimated 18% to 19% share of the worldwide flavors and fragrances market. Its primary rival is Swiss industry leader Givaudan, followed closely by major players DSM-Firmenich and Symrise in a heavily consolidated sector. IFF’s core advantage is massive formulation lock-in; once a food or perfume giant standardizes an IFF recipe, switching suppliers is rare due to reformulation risks. The downside is that its sprawling Health & Biosciences footprint adds operational overhead and margin pressure that more streamlined peers avoid.

Right now, IFF is focused on financial stabilization rather than expansion, posting flat net sales of $11.48 billion in 2024 matching its $11.48 billion total from 2023. That performance remains well below its 2022 peak of $12.44 billion, reflecting past integration friction and significant leverage. The current strategy centers on debt reduction, cost control, and portfolio pruning to rebuild compressed operating margins. This is no longer a top-line growth story; it is an operational turnaround focused on execution and cash flow discipline.

Key Financials

Market Cap

$22.56B

Revenue

$10.78B

EBITDA

$1.91B

Gross Margin

36.6%

Profit Margin

2.6%

Revenue Growth

1.8%

Total Cash

$569.00M

Total Debt

$6.28B

Free Cash Flow

-$1.72B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

87.54

Forward P/E

22.30

Beta

0.93

52-Week High

$89.32

52-Week Low

$59.75

EPS

$1.01

50-Day Avg

$84.65

200-Day Avg

$76.91

Price/Book

1.62

Technical Analysis

IFF trades at $88.42, just 0.79% below its $88.90 52-week high and 47.09% above its $59.97 low. The stock sits 98% of the way from that low to the high, so the trend is clearly strong but extended. Price is 4.27% above the 20-day moving average of $84.59. Momentum remains positive, with gains of 5.10% over five trading days and 5.20% over 20 trading days. Near-term support is $82.42, while the listed $88.20 resistance level has already been exceeded by the current price.

Recent News and Developments

IFF sets November 3 date for third-quarter results

IFF will release its third-quarter 2026 results after the market closes on November 3. Management will discuss the results and outlook in a webcast at 9:00 a.m. ET on November 4. Source: International Flavors & Fragrances

IFF shares jump 4% toward 52-week high

IFF rose 4.0% to $88.37 in midday trading on October 13, approaching its $89.32 52-week high. The move came while the S&P 500, Dow and Nasdaq were all lower, making IFF’s rally notably stock-specific. Source: Investing.com

Weiss upgrades IFF within Hold range

Weiss Ratings upgraded IFF from Hold with a C- grade to Hold with a C grade on October 8. It is an improvement, but the Hold rating shows Weiss still lacks conviction on the stock. Source: MarketBeat

Market Sentiment and Analyst Recommendations

Bull Case

IFF has strong price momentum, with the stock trading near its 52-week high after gaining 5.10% over five trading days. The October 13 rally was especially notable: shares rose 4.0% to $88.37 while the S&P 500, Dow, and Nasdaq were lower. Revenue is growing 1.8%, which is modest but positive. Seventeen analysts rate IFF a buy, with an average target of $96.24. That target represents about 8.8% upside from $88.42, while the high target of $105.00 implies substantially more room. Argus reinforced the bullish view by raising its target from $85 to $95, while Citi maintained its Buy rating despite trimming its target from $101 to $100.

Bear Case

The biggest problem is valuation: IFF trades at 87.54 times earnings while revenue is growing only 1.8%. That is a demanding multiple for such limited top-line growth. The balance sheet also carries $6.28 billion in debt against only $569 million in cash. Price risk is elevated because the stock is already 98% of the way through its 52-week range and only 0.79% below the high. The average analyst target of $96.24 offers about 8.8% upside, which is not especially compelling against the valuation and leverage risks. Weiss improved its grade from C- to C but kept IFF at Hold, showing that not every analyst sees enough strength to justify buying near the high.

What to Watch

IFF will release third-quarter 2026 results after the market closes on November 3. Management will discuss the results and outlook at 9:00 a.m. ET on November 4. Revenue growth is the key fundamental test because the current rate is only 1.8% and does not support an 87.54 P/E without improvement elsewhere. Investors should also track whether cash remains near $569 million and debt stays near $6.28 billion. Technically, holding above the $84.59 20-day moving average would keep the short-term trend intact, while a break toward $82.42 would weaken it. A sustained move above the $88.90 52-week high would confirm further strength, but failure near that level would raise the risk of a pullback.

Analyst Consensus

BUY

Based on 17 analyst opinions

Low Target

$76.00

Mean Target

$96.24

High Target

$105.00

Earnings and Financial Data

Sector

Basic Materials

Industry

Specialty Chemicals

Employees

21,500

Earnings & Dividends

Next Earnings

Nov 03, 2026

EPS (Trailing)

$1.01

Dividend Yield

188.0%

Payout Ratio

158.4%

Frequently Asked Questions

Is IFF a good stock to buy?

Seventeen analysts rate IFF a buy, and the stock has gained 5.10% over the last five trading days. The takeaway is that sentiment and momentum are bullish, but the 87.54 P/E makes the entry price demanding.

What is IFF’s price target?

The average analyst target is $96.24, with estimates ranging from $76.00 to $105.00. The takeaway is that analysts see upside from $88.42 on average, but the lowest target is below the current price.

Is IFF stock near its 52-week high?

IFF is trading at $88.42, only 0.79% below the technical 52-week high of $88.90. The takeaway is that the stock is near the top of its annual range.

What are IFF’s support and resistance levels?

Near-term support is $82.42, while the listed 30-day resistance level is $88.20. The takeaway is that the current $88.42 price is already above that resistance level, making $88.90 the next listed high to watch.

How much debt does IFF have?

IFF has $6.28 billion in total debt and $569 million in total cash. The takeaway is that debt materially exceeds the company’s reported cash position.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated October 14, 2026.